Deep CRISPR mutagenesis predicts cancer risk in Li-Fraumeni syndrome
Deep CRISPR mutagenesis predicts cancer risk in Li-Fraumeni syndrome

原文摘要
出版方登记 · OpenAlexTP53 encodes for the transcription factor TP53, which controls the expression of genes involved in cell cycle, apoptosis, senescence, stem cell differentiation, metabolism, and DNA repair.1 ∼50% of all human cancers harbor somatic TP53 mutations, while germline or postzygotic somatic mosaic TP53 pathogenic variants cause Li-Fraumeni syndrome (LFS [MIM: 151623]), a cancer predisposition syndrome associated with a lifelong increased risk for various solid tumors as well as hematologic neoplasms.2 A cancer surveillance protocol has been shown to statistically significantly improve long-term survival in individuals with LFS.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
来源:American Journal of Human Genetics · doi.org